デフォルト表紙
市場調査レポート
商品コード
1427938

爪真菌症の世界市場レポート 2024年

Onychomycosis Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
爪真菌症の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

爪真菌症の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には5.4%の年間複合成長率(CAGR)で44億5,000万米ドルに成長すると予想されます。予測期間で予想される成長は、併用薬物療法の採用、医療費の増加、爪真菌症の啓発キャンペーンの増加、遠隔医療サービスの拡大、局所製剤の進歩など、さまざまな要因に起因すると考えられます。この期間の注目すべき動向には、爪真菌症の診断と管理におけるデジタル技術の統合、市販(OTC)抗真菌薬の増加、患者に優しい治療計画の開発、爪真菌症治療における個別化医療への焦点、と研究開発のための製薬会社間の協力。

爪真菌症市場の予想される成長は、糖尿病患者の人口増加によって促進されると予想されます。不十分なインスリン合成または無効なインスリン利用を特徴とする糖尿病は、一般的に爪真菌症を引き起こす慢性疾患であり、一般的な足の問題を引き起こします。 爪真菌症を効果的に管理することは、糖尿病患者にとって合併症を防ぐために非常に重要です。注目すべきことに、国際糖尿病連盟は2021年12月、2021年には世界中で5億3,700万人(20~79歳)が糖尿病に罹患し、2030年までに6億4,300万人、2045年までに合計7億8,300万人に増加すると予測していると報告しました。 爪真菌症市場の成長の重要な推進力です。

製薬会社のグローバリゼーションは、爪真菌症市場の拡大に貢献しようとしています。この傾向には、製薬会社が国内市場や地域市場を超えて世界規模で事業を展開することが含まれています。世界の製薬会社は、爪真菌症を含むさまざまな健康状態に関する意識向上キャンペーンや教育活動を実施する上で重要な役割を果たしています。このような取り組みは、この疾患の有病率と利用可能な治療選択肢についての医療専門家と一般の人々の意識の向上に貢献しています。一例として、ドイツに本拠を置く外国貿易事務所であるGermany Trade and Investのデータによると、世界第4位で欧州最大の医薬品市場であるドイツでは、医薬品売上高が5.4%増加し、565億ユーロに達したことが明らかになりました。生物製剤の成長は特に顕著で、2021年から2022年の間に10.5%に達し、2022年には178億ユーロの収益を生み出し、国の製薬事業全体の3分の1を占めました。したがって、製薬会社のグローバリゼーションは、爪真菌症市場の成長を促進する上で重要な役割を果たしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の爪真菌症市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の爪真菌症の市場規模実績と成長、2018~2023年
  • 世界の爪真菌症市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の爪真菌症市場、タイプ別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 遠位爪下爪真菌症(DSO)
  • 白色表在性爪真菌症(WSO)
  • 近位爪下爪真菌症(PSO)
  • カンジダ爪真菌症
  • その他
  • 世界の爪真菌症市場、治療別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 薬物療法
  • 局所療法
  • その他
  • 世界の爪真菌症市場、流通チャネル別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 病院薬局
  • 小売薬局
  • その他

第7章 地域と国の分析

  • 世界の爪真菌症市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の爪真菌症市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 爪真菌症市場の競合情勢
  • 爪真菌症市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson Services Inc.
    • Merck &Co. Inc.
    • Bayer AG
    • Novartis AG

第31章 その他の大手と革新的な企業

  • GlaxoSmithKline PLC
  • Eli Lilly and Company
  • Sandoz International GmbH
  • Bausch Health Companies Inc.
  • Perrigo Company plc
  • Galderma Laboratories LP
  • Aurobindo Pharma Limited
  • Cipla Inc.
  • Dr.Reddy's Laboratories Ltd.
  • Apotex Inc
  • Lupin Limited
  • Amneal Pharmaceuticals Inc.
  • Alembic Pharmaceuticals Inc.
  • Kaken Pharmaceutical Co. Ltd.
  • Mayne Pharma Group Limited

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13782

Onychomycosis refers to a nail infection that can impact various parts of the nail, including the matrix, bed, or plate, affecting both toenails and fingernails. This common condition is caused by diverse fungi, including dermatophytes, yeasts, and molds.

The primary types of onychomycoses include distal subungual onychomycosis (DSO), white superficial onychomycosis (WSO), proximal subungual onychomycosis (PSO), candida onychomycosis, and others. Distal subungual onychomycosis (DSO) specifically targets the nails of the feet, and treatment options vary, encompassing oral antifungal drugs, topical antifungal treatments, or a combination of both. The therapeutic approaches involve drug treatment, topical therapy, and other interventions, with distribution channels including hospital pharmacies, retail pharmacies, and other relevant outlets.

The onychomycosis research report is one of a series of new reports from The Business Research Company that provides onychomycosis market statistics, including the onychomycosis industry's global market size, regional shares, competitors with onychomycosis market share, detailed onychomycosis market segments, market trends and opportunities, and any further data you may need to thrive in the onychomycosis industry. This onychomycosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The onychomycosis market size has grown strongly in recent years. It will grow from $3.4 billion in 2023 to $3.61 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth observed during the historic period can be attributed to several factors, including limited treatment options, an aging population, a rise in the incidence of diabetes, the expansion of the pharmaceutical industry, and an increased awareness of fungal infections.

The onychomycosis market size is expected to see strong growth in the next few years. It will grow to $4.45 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The anticipated growth in the forecast period can be attributed to various factors, including the adoption of combination drug therapies, a rise in healthcare expenditure, increased awareness campaigns for onychomycosis, the expansion of telemedicine services, and advancements in topical drug formulations. Notable trends during this period encompass the integration of digital technologies in onychomycosis diagnosis and management, an increase in over-the-counter (OTC) antifungal products, the development of patient-friendly treatment regimens, a focus on personalized medicine in onychomycosis treatment, and collaborations between pharmaceutical companies for research and development.

The anticipated growth in the onychomycosis market is expected to be propelled by the increasing population of individuals with diabetes. Diabetes, characterized by inadequate insulin synthesis or ineffective insulin utilization, is a chronic disease that commonly leads to onychomycosis, posing a prevalent foot problem. Effectively managing onychomycosis is crucial for individuals with diabetes to prevent complications. Notably, the International Diabetes Federation reported in December 2021 that diabetes affected 537 million people globally (aged 20-79) in 2021, with projections estimating an increase to 643 million by 2030 and a total of 783 million by 2045. This surge in diabetes cases is a key driver for the growth of the onychomycosis market.

The globalization of pharmaceutical companies is poised to contribute to the expansion of the onychomycosis market. This trend involves pharmaceutical companies extending their operations beyond domestic or local markets to operate on a global scale. Global pharmaceutical companies play a vital role in conducting awareness campaigns and educational initiatives on various health conditions, including onychomycosis. Such initiatives contribute to increased awareness among healthcare professionals and the general public regarding the condition's prevalence and available treatment options. As an example, data from Germany Trade and Invest, a Germany-based office for foreign trade, reveals that Germany, being the fourth-largest pharmaceutical market globally and the largest in Europe, experienced a 5.4% increase in pharmaceutical sales to reach EUR 56.5 billion in 2022. The growth in biologics was particularly notable, reaching 10.5% between 2021 and 2022, generating EUR 17.8 billion in revenue in 2022 and constituting one-third of the country's entire pharmaceutical business. The globalization of pharmaceutical companies is thus playing a significant role in driving the growth of the onychomycosis market.

Product innovation stands out as a prominent trend gaining traction in the onychomycosis market, with major companies actively pursuing the development of innovative products to maintain their market positions. For instance, in December 2021, Bausch Health Companies Inc., a Canada-based pharmaceutical company, introduced Julia (aliconazole) topical solution for onychomycosis treatment. Notably, Julia received approval from the American Podiatric Medical Association (APMA), underscoring its recognition for supporting foot health when used consistently in a daily foot care regimen and professional treatment program.

Major companies in the onychomycosis market are focusing on the development of innovative formulations to address specific challenges associated with the condition and enhance treatment outcomes. Lupin Limited, an India-based pharmaceutical company, exemplifies this trend with the launch of Tavaborole Topical Solution in July 2021. This oxaborole antifungal solution is designed for the topical treatment of onychomycosis of the toenails caused by Trichophyton rubrum or Trichophyton mentagrophytes, serving as the generic equivalent of Anacor Pharmaceuticals Inc.'s Kerydin Topical Solution 5%, with an estimated annual sale of USD 53 million in the U.S.

In December 2021, Kaken Pharmaceutical Co. Ltd., a US-based pharmaceutical company, acquired Artha Therapeutics Inc. This undisclosed-sum acquisition allows Kaken to enhance its research and development capabilities by leveraging Artha's technologies and expertise in drug repositioning. Artha Therapeutics Inc., a Japan-based biopharmaceutical company, specializes in providing topical onychomycosis treatment in Japan. This acquisition reflects a strategic move to leverage synergies and further develop onychomycosis treatment options.

Major companies operating in the onychomycosis market report are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company PLC, Galderma Laboratories LP, Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Apotex Inc., Lupin Limited, Amneal Pharmaceuticals Inc., Alembic Pharmaceuticals Inc., Kaken Pharmaceutical Co. Ltd., Mayne Pharma Group Limited, Wockhardt Ltd., Sato Pharmaceutical Co. Ltd., Anacor Pharmaceuticals Inc., Jubilant Cadista Pharmaceuticals Inc., Moberg Pharma AB, Medimetriks Pharmaceuticals Inc., Blueberry Therapeutics Ltd., Hallux Inc., NovaBiotics Ltd., Zydus Cadila Healthcare Limited.

North America was the largest region in the onychomycosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the onychomycosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The onychomycosis market includes revenues earned by services such as combination therapy, oral antifungal medications, itraconazole, ketoconazole, griseofulvin, and terbinafine. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Onychomycosis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on onychomycosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for onychomycosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The onychomycosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Distal Subungual Onychomycosis (DSO); White Superficial Onychomycosis (WSO); Proximal Subungual Onychomycosis (PSO); Candida Onychomycosis; Other Types
  • 2) By Treatment: Drug Treatment; Topical Therapy; Other Treatments
  • 3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Other Distribution Channels
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Onychomycosis Market Characteristics

3. Onychomycosis Market Trends And Strategies

4. Onychomycosis Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Onychomycosis Market Size and Growth

  • 5.1. Global Onychomycosis Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Onychomycosis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Onychomycosis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Onychomycosis Market Segmentation

  • 6.1. Global Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Distal Subungual Onychomycosis (DSO)
  • White Superficial Onychomycosis (WSO)
  • Proximal SubUngal Onychomycosis (PSO)
  • Candida Onychomycosis
  • Other Types
  • 6.2. Global Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Treatment
  • Topical Therapy
  • Other Treatments
  • 6.3. Global Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

7. Onychomycosis Market Regional And Country Analysis

  • 7.1. Global Onychomycosis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Onychomycosis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Onychomycosis Market

  • 8.1. Asia-Pacific Onychomycosis Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Onychomycosis Market

  • 9.1. China Onychomycosis Market Overview
  • 9.2. China Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Onychomycosis Market

  • 10.1. India Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Onychomycosis Market

  • 11.1. Japan Onychomycosis Market Overview
  • 11.2. Japan Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Onychomycosis Market

  • 12.1. Australia Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Onychomycosis Market

  • 13.1. Indonesia Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Onychomycosis Market

  • 14.1. South Korea Onychomycosis Market Overview
  • 14.2. South Korea Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Onychomycosis Market

  • 15.1. Western Europe Onychomycosis Market Overview
  • 15.2. Western Europe Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Onychomycosis Market

  • 16.1. UK Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Onychomycosis Market

  • 17.1. Germany Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Onychomycosis Market

  • 18.1. France Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Onychomycosis Market

  • 19.1. Italy Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Onychomycosis Market

  • 20.1. Spain Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Onychomycosis Market

  • 21.1. Eastern Europe Onychomycosis Market Overview
  • 21.2. Eastern Europe Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Onychomycosis Market

  • 22.1. Russia Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Onychomycosis Market

  • 23.1. North America Onychomycosis Market Overview
  • 23.2. North America Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Onychomycosis Market

  • 24.1. USA Onychomycosis Market Overview
  • 24.2. USA Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Onychomycosis Market

  • 25.1. Canada Onychomycosis Market Overview
  • 25.2. Canada Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Onychomycosis Market

  • 26.1. South America Onychomycosis Market Overview
  • 26.2. South America Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Onychomycosis Market

  • 27.1. Brazil Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Onychomycosis Market

  • 28.1. Middle East Onychomycosis Market Overview
  • 28.2. Middle East Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Onychomycosis Market

  • 29.1. Africa Onychomycosis Market Overview
  • 29.2. Africa Onychomycosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Onychomycosis Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Onychomycosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Onychomycosis Market Competitive Landscape And Company Profiles

  • 30.1. Onychomycosis Market Competitive Landscape
  • 30.2. Onychomycosis Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson Services Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Onychomycosis Market Other Major And Innovative Companies

  • 31.1. GlaxoSmithKline PLC
  • 31.2. Eli Lilly and Company
  • 31.3. Sandoz International GmbH
  • 31.4. Bausch Health Companies Inc.
  • 31.5. Perrigo Company plc
  • 31.6. Galderma Laboratories LP
  • 31.7. Aurobindo Pharma Limited
  • 31.8. Cipla Inc.
  • 31.9. Dr.Reddy's Laboratories Ltd.
  • 31.10. Apotex Inc
  • 31.11. Lupin Limited
  • 31.12. Amneal Pharmaceuticals Inc.
  • 31.13. Alembic Pharmaceuticals Inc.
  • 31.14. Kaken Pharmaceutical Co. Ltd.
  • 31.15. Mayne Pharma Group Limited

32. Global Onychomycosis Market Competitive Benchmarking

33. Global Onychomycosis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Onychomycosis Market

35. Onychomycosis Market Future Outlook and Potential Analysis

  • 35.1 Onychomycosis Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Onychomycosis Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Onychomycosis Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer